Patent · US Active

Indol-2-yl-piperazin-1-yl-methanone derivatives

US7507736B2 · kind B2 · utility

1Cited by

0References

22Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Matthias Nettekoven · Weil am Rhein, DE
Jean-Marc Plancher · Rixheim, FR
Hans Richter · Weil am Rhein, DE
Olivier Roche · Folgensbourg, FR
Sven Taylor · Riedisheim, FR

Key dates

Filing date	Jan 25, 2008
Grant date	Mar 24, 2009
Priority date	—
Expiry date	Jan 25, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D451/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula Iwherein A and R1 to R4 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.